1. The agglutinating properties of a crude gluten digest, purified gliadin fractions and established plant lectins were investigated using mammalian erythrocytes, rat enterocytes and normal and coeliac human enterocytes as the target systems.
Introduction
Coeliac disease, a condition which affects children and adults, is characterized by an abnormal jejunal Correspondence: Dr M. J. G. Farthing, Department of Gastroenterology, St Bartholomew's Hospital, West Smithfield, London EClA 7BE. mucosa which improves in the absence of dietary gluten. The toxic moiety has been shown by many to be present in the gliadin fraction of wheat gluten [l] . The mechanism( s) by which gliadin produces jejunal damage in coeliac disease has not been clearly established. One hypothesis is that toxicity is mediated through a lectin-like interaction of gliadin, or some portion thereof, with enterocytes of a susceptible individual [2] . By definition, a lectin is a sugarbinding protein or glycoprotein of non-immune origin which by its polyvalent nature agglutinates cells and/or precipitates glycoconjugates [3] . Many plant lectins are biologically active in vivo and in a variety of mammalian cell systems in vitro, causing lymphocyte blast transformation [4] and cytotoxicity [5] . Concanavalin A (Con A ) and wheat germ agglutinin (WGA) are injurious to mammalian intestine, producing morphological changes in the rat similar to those exhibited by patients with coeliac disease [6] .
It has been proposed that the epithelial cells of patients with coeliac disease possess an abnormal surface glycoprotein( s), which contains a sugar residue or residues recognized by, and available for binding to, a lectin component of gliadin [2] . Thus, attachment of gliadin to the cell membrane in this manner is purported to produce epithelial cell damage in the same way that other plant lectins are cytotoxic [5] . There have been several reports which support this hypothesis [7-91 using a variety of experimental approaches.
We have extended these studies by investigating possible cell agglutinating properties of crude and purified gliadins using three intact-cell systems, including normal and coeliac human intestinal epithelial cells.
Materials and methods
The plant lectins Con A, phytohaemagglutinin (PHA), WGA and peanut agglutinin (PNA) were obtained from Sigma Chemical Co. Ltd (Poole, Dorset) and used as received. An enzyme digest of gluten, Frazer's fraction 111, was prepared as previously described [ 101 and residual proteolytic enzyme activity was destroyed by incubation for 60 min at 56°C [ 111. Purified gliadins were prepared by ion exchange and gel filtration chromatography as described previously [ 121. Gliadins were eluted from Sephadex SPC-25 ion exchanger using an ammonium chloride gradient. y-and w-gliadins were eluted by 0.0 1-0.07 mol/l ammonium chloride, P-gliadins between 0.075 and 0.12 mol/l and agliadins (with a minor i?-gliadin contaminant which was reduced by further gel filtration) with 0.12-0.17 molA. Thus three gliadin fractions, (i) a/?,& (ii) /3,-syw ('a-free') and (iii) P3-5 yw ('high molecular weight') gliadin, as represented schematically in Fig.  1 , were produced for the present study. We have shown that Frazer's fraction 111 and the gliadincontaining fraction (same batches as were used in the present study) caused alteration in coeliac mucosa when given in challenges in vivo, whereas the 'a-free' and 'high molecular weight' fractions were without effect [13] .
Lectin activity of the above gliadin fractions was assessed by determining their ability to agglutinate mammalian erythrocytes, isolated rat enterocytes and isolated human jejunal enterocytes from coeliac patients and histologically normal controls. Pure plant lectins were used in each case as positive controls, and bovine serum albumin (BSA) as a negative control in experiments with human enterocytes.
Mammalian erythrocytes
Human, rat, rabbit, guinea pig, horse and ox erythrocytes were obtained fresh and stored for up to 10 days in Alsever's solution at 4°C. Before use in the microhaemagglutination assay, erythrocytes were washed three times in phosphate-buffered saline (PBS), pH 7.2, and resuspended as a 2% suspension in PBS containing 2 mg of BSNml. Haemagglutination was also performed after the erythrocytes had been treated with trypsin (EC 3.4.21.4, 1 mg/ml for 30 min at 37°C) or neuraminidase (EC 3.2.1.18, 0.25 mg/ml, pH 6 for 15 min at 37°C). Enzyme reactions were stopped by dilution with PBS at 4"C, after which the erythrocytes were washed three times in PBS.
Rat enterocytes
Non-fasted male Wistar rats (approximately 250 g) were killed by cervical dislocation and epithelial cells were isolated from the proximal small intestine by serial citrateEDTA elution [ 141. Separate villus and crypt enterocyte populations were characterized by their specific sucrase and alkaline phosphatase activities and by their incorporation of tritiated thymidine using the methods of Dahlqvist [15] , Eicholz [16] and Verbin & Farber [ 171 respectively.
Enterocytes were centrifuged (265 g for 10 min, 4°C) then resuspended in an isotonic 10 mmolA 4-( 2-hydroxyethy1)-1-piperazinepropanesulphonic acid-saline buffer containing 2 mmolA calcium chloride (HSC-buffer). Single-cell suspensions were produced by filtering the eluates through lightly packed glass-wool pads; cells were washed three times in PBS before enzyme treatment with trypsin (0.1 ms/ml, 37"C, 15 min) or neuraminidase (0.25 mdml, 37T, 10 min). After enzyme treatment enterocytes were washed a further three times in PBS and resuspended at loh cells/ml in HSC-buffer.
Viability of enterocytes, assessed by trypan blue (0.05%) exclusion immediately before exposure to the agglutinins, was 75.5% f 10.4% (mean f SD, n = 4).
Human enterocytes
Epithelial cells were isolated from routine human jejunal biopsy specimens from five untreated coeliac patients with subtotal villus atrophy, four coeliac patients with partial villus atrophy who had been treated for 1.5-10 years with a gluten-free diet, and five control patients being investigated for diarrhoea1 disease in whom no abnormality of intestinal structure or function was detected.
The jejunal mucosa was incubated for 7.5 min at 37°C in pre-warmed sodium citrate solution [14], with gentle vortexing for 15 s every 5 min. The solution was discarded, followed by two sequential incubations with sodium EDTA solution at 37°C for 20 min resulting in the isolation of epithelial cells without disruption of the lamina propria. The cells collected were pooled, washed three times in HSC-buffer containing manganese sulphate (2 mmoV1) and then used in a microagglutination assay employing 2.5 X lo4 cells/well. Viability of these enterocytes assessed by trypan blue exclusion was 7 6 % f 6 . 5 % ( m e a n f s~, n = 9 ) .
Agglutination assay
Pure plant lectins (1 gA) were doubly diluted across a microplate (Flow Laboratories, Irvine, Scotland, U.K.) in buffered saline solutions to give a final volume of 25 pl. PBS was used in experiments with mammalian erythrocytes and rat enterocytes whereas HSC-buffer with Mn2+ ions was used with human enterocytes. An equal volume of cells was then added to each well, the plates were covered and incubated for 60 min: the mammalian erythrocytes at room temperature (23"C), and the isolated enterocytes at 37°C. Gliadin preparations were diluted in the same manner as the plant lectins. This resulted in final gliadin concentrations of 15-150 mgA for the erythrocytes and rat enterocytes, 50 mgA for the purified gliadin fractions and 1000 mgA for Frazer's fraction I11 with human enterocytes.
Haemagglutination was scored visually and confirmed microscopically. Agglutination of the isolated enterocytes was determined directly by inverted phase contrast microscopy (Zeiss ID02, Zeiss, West Germany). Agglutination assays were read 'blind' by an observer unaware of the agglutinin being tested.
Results

Mammalian erythrocytes
Agglutination end-points for pure plant lectins (Con A, PHA, PNA) ranged from 4 pgA to 16 mgA depending on erythrocyte species and enzyme pretreatment. Table 1 shows the end-point concentration of agglutinins with untreated erythrocytes. Con A and PHA were potent cell agglutinins, with similar activities. PNA had little or no agglutinating activity unless the erythrocytes had been pretreated with neuraminidase, after which it proved an equipotent agglutinin as expected. Trypsin treatment generally increased the susceptibility of erythrocytes to Con A and PHA agglutination, but did not render them susceptibe to PNA activity. Crude and purified gliadins failed to induce agglutination of untreated or enzyme pretreated mammalian erythrocytes when added at concentrations within the 'active' range of pure plant lectins.
Isolated rat enterocytes
The sucrase and alkaline phosphatase specific activity and [3H]thymidine incorporation data shown in Fig. 2 confirm that separate villus and crypt cell populations were obtained by the citrate/ EDTA elution method. Table 2 summarizes the agglutination study performed with rat enterocytes. Pure plant lectins (Con A, PHA, PNA and WGA) caused cell agglutination with end-point concentrations ranging from 1 to 66 mgA. Prior enzyme treatment of the cells had little effect on their susceptibility to lectin-induced agglutination although neuraminidase treatment was, as expected, required for PNA-induced agglutination. Crypt cells were more susceptible to lectin agglutination than villus cells in most cases.
Crude gliadin and pure aB,& 'a-free' and 'high molecular weight' gliadins failed to produce agglutination of isolated rat villus and crypt enterocytes even after enzyme pretreatment of the cells.
Isolated human enterocytes
The method of enterocyte isolation from jejunal mucosa specimens yielded approximately 6. Table 3 . Con A and PHA were potent cell agglutinins with similar activities, whereas the gliadin fractions (including Frazer's fraction I11 at high concentration) failed to agglutinate normal or coeliac enterocytes.
Discussion
Our studies using mammalian erythrocytes, isolated rat enterocytes and isolated normal and coeliac human enterocytes have failed to demonstrate cell agglutinating properties in a crude enzyme digest of gluten or in purified a,P and high molecular weight gliadin fractions. These data do not support the 'lectin theory' for the pathogenesis of coeliac disease and are in conflict with the findings of others using different experimental test systems [7- 91. However, these negative findings might have been explained by loss of biological activity during preparation of the gliadin fractions, but preservation of biological integrity of these same gliadin preparations had been confirmed previously in challenges in vivo in coeliac patients. The a-gliadin fraction and Frazer's fraction I11 caused alteration of coeliac mucosa in remission, whereas the p, y-, and w-gliadins were without effect [13] . Secondly, agglutinating activity could have been overlooked due to the relatively poor solubility of gliadin in physiological solutions (100 mgA). Plant lectins, 1 2 ) ( n = 1 0 ) ( n = 6 ) ( n = 6 ) ( n = 6 ) ( n = 6 ) ( n = 6 ) ( n = 6 ) ( n = 6 ) ( n = 4 ) ( n = 2 ) ( n = 3 ) ( n = 2 ) ( n = 2 ) ( n = 2 ) ( n = 2 ) however, were active agglutinins at these and lower concentrations, suggesting that we have not failed to detect biologically important agglutinating activity. Frazer's fraction III is substantially more water soluble, but even when used at high concentration (1 gA), cell agglutination was not observed. Another methodological aspect which might explain these negative results is the condition of the intestinal epithelial cells after their isolation. This process could conceivably have damaged the microvillus membrane and depleted or removed the putative lectin receptor. Receptors for other plant lectins, however, clearly survived the isolation process and it would not seem unreasonable to assume that the hypothetical gliadin receptor was also intact. Our findings clearly differ from those of some investigators who have used a variety of detector systems. Douglas [7] radiolabelied a digest of gluten and examined its binding to homogenates of normal and coeliac human intestinal mucosa. The binding of this protein digest was greatest with homogenates derived from coeliac intestinal mucosa and was inhibited by the monosaccharide rhamnose. It is unclear, however, whether the gliadin preparation was interacting with the intestinal cell surface membrane or some other cell component.
Kottgen et al. [8] partially purified a gluten digest by Sephadex G-50 gel filtration chromatography and examined its interaction with serum glycoproteins and rat intestinal brush border membrane by laser nephelometry. Binding was greatest to serum glycoproteins of the 'high mannose' type, and with brush border membranes from rat crypt cells. The interaction was inhibited by low concentrations of mannan (a polymannose glycopeptide) and by high concentrations of mannose (0.3 molll), suggesting that this gluten digest contained a mannose-binding lectin. Rawcliffe et al. [ 181, however, have repeated the initial part of this study, using a mannose-rich protein ovalbumin, but were unable to confirm the interaction of Frazer's fraction I11 with this protein.
Further evidence for lectin activity in gliadin has been provided by Auricchio et al. [9] , who found agglutinating activity in gliadin digests of hexaploid wheat species using K562(S) cells as the target.
Agglutinating activity was inhibited by mannan, Dmannose and N-acetylglucosamine.
Thus, controversy continues regarding the possible lectin activity of gliadin. In the present study we consider we have used a biologically relevant assay system using cells which are of primary importance in the aetiopathogenesis of coeliac disease, and a range of purified and crude gliadin fractions of predetermined toxicity to coeliac mucosa. A s all the cells in this study including the coeliac enterocytes were not susceptible (under the experimental conditions described) to the proposed agglutinating properties of gliadin, we must conclude from our data that it is unlikely that lectin activity exists in gliadin and that the mucosal damage caused by these proteins in coeliac disease is probably mediated by some other process. We cannot exclude the possibility, however, that gluten might be 'activated' by an as yet undefined luminal factor to produce lectin activity. A further recent report suggests that weak lectin-like activity in gliadin preparations relates to contamination with WGA and not to gliadin itself [19] . Variation in results between investigators may be accounted for at least in part by different degrees of WGA contamination of their test preparations.
